WordNet

a process in which individuals (or small groups) penetrate an area (especially the military penetration of enemy positions without detection)
either of two saclike respiratory organs in the chest of vertebrates; serves to remove carbon dioxide and provide oxygen to the blood

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 間質性肺疾患における肺生検結果の解釈 interpretation of lung biopsy results in interstitial lung disease
2. 特発性間質性肺炎：臨床症状および病理 idiopathic interstitial pneumonias clinical manifestations and pathology
3. 進行非小細胞肺癌に対する遺伝子型による個別治療 personalized genotype directed therapy for advanced non small cell lung cancer
4. 肺移植後の免疫抑制の維持 maintenance immunosuppression following lung transplantation
5. 肺小細胞癌の治療プロトコル treatment protocols for small cell carcinoma of the lung

Nishiura H.SourceDepartment of Molecular Pathology, Kumamoto University Graduate School, Honjyo 1-1-1, Kumamoto, 860-8556, Japan, seino@kumamoto-u.ac.jp.
Advances in experimental medicine and biology.Adv Exp Med Biol.2013;734:111-21.
When acute inflammatory states are induced by treatment with chemical mediators in C5-deficient mice, neutrophil influxes are commonly decreased. Therefore, the neutrophil C5a receptor (C5aR) is believed to be a member of the pro-inflammatory receptors. However, C5aR deficiency endows mouse neutroph
PMID 22990698

Corticosteroid treatment inhibits airway hyperresponsiveness and lung injury in a murine model of chemical-induced airway inflammation.

Wigenstam E, Jonasson S, Koch B, Bucht A.SourceSwedish Defence Research Agency, Division of CBRN Defence and Security, Umeå, Sweden. elisabeth.wigenstam@foi.se
Toxicology.Toxicology.2012 Nov 15;301(1-3):66-71. doi: 10.1016/j.tox.2012.06.020. Epub 2012 Jul 6.
CONTEXT: Exposure to toxic alkylating mustard agents causes both acute and long-term effects to the lungs as indicated by increased number of inflammatory cells in airways, lung edema and lung tissue fibrosis. We have previously demonstrated that treatment with the corticosteroid dexamethasone 1 h a
PMID 22776411

Sphingosine-1-phosphate as a mediator involved in development of fibrotic diseases

Takuwa Yoh,Ikeda Hitoshi,Okamoto Yasuo,Takuwa Noriko,Yoshioka Kazuaki
Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids 1831(1), 185-192, 2013-01
… Fibrosis occurs in various organs including the lung, heart, liver and kidney, resulting in loss of normal tissue architecture and functions. … Emerging evidence in recent years shows that sphingosine-1-phosphate (S1P) acts on several types of target cells and is engaged in pro-fibrotic inflammatory process and fibrogenic process through multiple mechanisms, which include vascular permeability change, leukocyte infiltration, and migration, proliferation and myofibroblast differentiation of fibroblasts. …
NAID 120004966619